| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/03/2001 | EP1065209A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2001 | EP1065207A1 Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
| 01/03/2001 | EP1064952A2 Methods and compositions for the suppression of neu mediated transformations |
| 01/03/2001 | EP1064951A2 Erythropoietin derivatives |
| 01/03/2001 | EP1064551A1 Development of human monoclonal antibodies and uses thereof |
| 01/03/2001 | EP1064403A1 Antisense modulation of pecam-1 |
| 01/03/2001 | EP1064402A1 Antisense modulation of lfa-3 |
| 01/03/2001 | EP1064392A2 Multigene vectors |
| 01/03/2001 | EP1064391A1 Antisense modulation of human mdm2 expression |
| 01/03/2001 | EP1064390A1 Enhanced anti-tumor immunity |
| 01/03/2001 | EP1064388A1 Human casb12 polypeptide, a serine protease |
| 01/03/2001 | EP1064383A2 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
| 01/03/2001 | EP1064379A2 Human nucleic acid sequences from tissue of breast tumors |
| 01/03/2001 | EP1064378A2 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/03/2001 | EP1064377A1 Casb414: antigen overexpressed in several tumours |
| 01/03/2001 | EP1064375A2 Human calcium-binding proteins |
| 01/03/2001 | EP1064372A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/03/2001 | EP1064371A2 Isolated mammalian membrane protein genes and related reagents |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064362A1 Nek1-related protein kinase |
| 01/03/2001 | EP1064308A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 01/03/2001 | EP1064307A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof |
| 01/03/2001 | EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 01/03/2001 | EP1064298A2 Inhibitors of caspases |
| 01/03/2001 | EP1064294A1 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them |
| 01/03/2001 | EP1064291A1 Methods of synthesizing gm3 |
| 01/03/2001 | EP1064289A1 Heterocyclic signal transduction inhibitors, compositions containing them |
| 01/03/2001 | EP1064285A1 Novel cephalotaxane derivatives and process for their preparation |
| 01/03/2001 | EP1064284A1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 01/03/2001 | EP1064280A1 Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents |
| 01/03/2001 | EP1064279A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 01/03/2001 | EP1064277A1 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 01/03/2001 | EP1064264A1 Cytotoxic metal chelators and methods for making and using same |
| 01/03/2001 | EP1064257A1 Anti-tumour agents |
| 01/03/2001 | EP1064253A1 Anti-tumour agents |
| 01/03/2001 | EP1064027A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 01/03/2001 | EP1064023A1 Products in the treatment of cancer |
| 01/03/2001 | EP1064022A1 Hla-binding peptides and their uses |
| 01/03/2001 | EP1064018A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 01/03/2001 | EP1064014A2 Medicament for preventing or treating papilloma virus-specific tumors |
| 01/03/2001 | EP1064000A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders |
| 01/03/2001 | EP1063998A1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/03/2001 | EP1063997A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 01/03/2001 | EP1063990A1 Therapy of estrogen-associated disorders |
| 01/03/2001 | EP1063985A1 Benzoates derivatives for inhibiting angiogenesis |
| 01/03/2001 | EP1063887A1 P53-dependent secretion of growth inhibitory factors |
| 01/03/2001 | EP0832057B1 Diaromatic propynyl or dienyl compounds |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | EP0807183B1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 01/03/2001 | CN1278865A Tumor-specific antigens, methods for their production and their use for immunization and diagnosis |
| 01/03/2001 | CN1278864A Genetically modified tumor-targeted bacteria with reduced virulence |
| 01/03/2001 | CN1278825A Sarcodictyin and eleutherobin useful for stabilising microtubules |
| 01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278806A Aminothiazole inhibitors of cyclin dependent protein kinasses of cells |
| 01/03/2001 | CN1278805A Novel heterocyclioally substituted and a-hydroxycarboxlic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 01/03/2001 | CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/03/2001 | CN1278725A Indeno [1,2-c]-naphtho [1,2-C]- and benzo [6,7] cyclohepta [1,2-C] pyrazole derivatives |
| 01/03/2001 | CN1278724A Indeno [1,2-c] pyrazole derivatives for inhibiting tyrosine kinase activty |
| 01/03/2001 | CN1278447A Pharmaceutical kit with 1-hydroxy ethylidene diphosphonate and its preparation and use |
| 01/03/2001 | CN1278434A Tumor pain relieving ointment and its preparation |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060164C SIN-IA cyclodextriun inclusion complexes |
| 01/03/2001 | CN1060079C Chinese herbal medicine composition for curing leukemia |
| 01/03/2001 | CN1060078C Chinese herbal medicine composition for curing malignant lymphoma |
| 01/03/2001 | CN1060071C Oral liquid for treating lung cancer and intestinal cancer and preparing process thereof |
| 01/03/2001 | CN1060064C Non-toxic sedative anticancer Chinese medicine capsule |
| 01/03/2001 | CN1060051C Anti-cancer compn. and prepn. thereof |
| 01/03/2001 | CN1060038C Elemene emulsion injection and its preparing process |
| 01/02/2001 | US6169104 Compounds bind tubulin and exhibit anti-mitotic properties; using such compounds to inhibit abnormal cell mitosis and, in particular, to inhibit tumor cell growth |
| 01/02/2001 | US6169096 For inhibiting tumor growth in a mammal |
| 01/02/2001 | US6169095 For prevention and/or treatment of bradykinin or its analogues mediated diseases in the eye, such as allergy, inflammation and pain of the eye |
| 01/02/2001 | US6169091 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6169087 An enzyme inhibitor for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, obesity, autoimmune diseases, diseases with dysfunctions of the coagulation system, allergic diseases, cancer, psoriasis |
| 01/02/2001 | US6169080 Highly lipophilic camptothecin derivatives |
| 01/02/2001 | US6169075 Antitumor agent inhibiting the proliferation of a range of rapidly dividing tumour cells like melanoma and/or lymphoma cells |
| 01/02/2001 | US6169073 An oligopeptide or polypeptide for activating dna binding of wild-type p53 and select tumor-derived p53 mutants; use in therapy of cancer and other disorders characterized by excessive proliferation of certain cells and tissues |
| 01/02/2001 | US6169072 Cyclic adhesion inhibitors |
| 01/02/2001 | US6168950 Compound 8 to 30 nucleotides in length which specifically hybridizes and inhibits gene expression of human mitogen-activated protein kinase kinase kinase 1; anticarcinogenic/antiproliferative agents |
| 01/02/2001 | US6168946 gp75 as a tumor vaccine for melanoma |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168807 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | US6168777 In vivo delivery of radioactive compositions which are delivered as a fluid to the solid mass tumor; subsequent solidification of this composition in the prostate results in delivery of a controlled amount of radiation to the prostate. |
| 01/02/2001 | CA2114156C Elucidation and synthesis of selected pentapeptides |
| 01/02/2001 | CA2086918C Biologically active compounds from blue-green algae |
| 01/02/2001 | CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 01/02/2001 | CA2009604C Diaryl-substituted heterocyclic compounds, their preparation and drugs and cosmetics obtained therefrom |
| 12/29/2000 | CA2300467A1 Cancer vaccines |
| 12/28/2000 | WO2000078980A1 Method for producing plants with increased flavonoid and phenolic compound content |
| 12/28/2000 | WO2000078955A1 Epithelial cell growth inhibitors |
| 12/28/2000 | WO2000078954A2 Human transcriptional regulator proteins |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078949A1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 12/28/2000 | WO2000078941A2 Methods and products for manipulating uncoupling protein expression |
| 12/28/2000 | WO2000078939A2 Vectors for the treatment of tumors by gene therapy |